Moreover, an extensive transcriptomic and metabolomic characterization of CD133+ HCC CSCs revealed the central role of the oncogene Myc in their rearrangement of glycolytic metabolism [54]. The gene discussed is PROM1; the disease is hepatocellular carcinoma.